Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2001, for Unitrin, Inc. (Note: The request metadata lists "KEMPER Corp," but the filing text explicitly identifies the registrant as Unitrin, Inc.). Unitrin operates through five segments: Multi Lines Insurance, Specialty Lines Insurance, Life and Health Insurance, Consumer Finance, and Unitrin Direct. The company also manages significant corporate investments, including holdings in Northrop Grumman and Baker Hughes.
Key Financial Metrics
| Metric | Nine Months Ended Sept 30, 2001 | Nine Months Ended Sept 30, 2000 | Three Months Ended Sept 30, 2001 | Three Months Ended Sept 30, 2000 |
|---|---|---|---|---|
| Total Revenues | $2,020.4 million | $1,488.4 million | $508.6 million | $496.1 million |
| Net Income | $393.0 million | $63.1 million | $20.1 million | $(4.3) million |
| Diluted EPS | $5.78 | $0.91 | $0.30 | $(0.07) |
| Net Cash from Operating Activities | $164.3 million | $77.1 million | N/A | N/A |
| Total Assets | $7,275.8 million | $6,164.8 million | N/A | N/A |
| Total Liabilities | $5,185.7 million | $4,463.6 million | N/A | N/A |
| Shareholders' Equity | $2,090.1 million | $1,701.2 million | N/A | N/A |
| Notes Payable | $207.8 million | $180.0 million | N/A | N/A |
Material Changes vs. Prior Period
- Investment Gains: The primary driver of the significant increase in Net Income was a pre-tax accounting gain of $562.1 million (after-tax $362.4 million) recognized in the second quarter of 2001. This resulted from the acquisition of Unitrin's former investee, Litton Industries, by Northrop Grumman Corporation, which converted Unitrin's equity stake into cash and Northrop stock.
- Insurance Segment Performance:
- Multi Lines Insurance: Operating loss widened to $42.9 million (9 months) due to increased storm losses ($62.2 million), large losses, and adverse reserve development ($11.6 million). The GAAP Combined Ratio was 117.5%.
- Specialty Lines Insurance: Operating loss increased to $12.9 million (9 months) driven by higher losses, including storm losses, which offset premium growth.
- Life and Health Insurance: Operating profit improved to $73.9 million (9 months), largely due to a $48.8 million charge recorded in the prior year for settlement estimates related to industrial life insurance litigation.
- Consumer Finance: Operating profit increased to $22.6 million (9 months) due to a higher level of loans outstanding, despite a slight increase in the provision for loan losses.
- Unitrin Direct: The new direct marketing segment recorded an operating loss of $15.6 million (9 months) due to upfront marketing and start-up costs, consistent with expectations for a new business unit.
Guidance, Outlook, Risks, and Unusual Items
- Investment Outlook: Management expects ongoing annual reported net income to decrease by approximately $12.2 million due to the Litton transaction (loss of equity income), but expects annual after-tax cash flow to increase by approximately $26.0 million due to dividends from Northrop stock.
- Strategic Transactions: Unitrin is proceeding with a tax-free spin-off of its equity ownership in Curtiss-Wright Corporation to shareholders, pending shareholder approval scheduled for October 26, 2001.
- Legal Proceedings: The company faces numerous lawsuits regarding alleged racial discrimination in industrial life insurance pricing. While a Florida appellate court ruled in Unitrin's favor regarding premium collection orders in September 2001, the company continues settlement discussions. A $32.4 million after-tax charge was recorded in 2000 for estimated settlement costs; actual costs may vary.
- Market Risk: The company holds significant equity positions in Northrop Grumman ($993.8 million) and Baker Hughes ($109.9 million), exposing it to market volatility in the defense and oil/gas sectors. A 10% drop in the S&P 500 would result in an estimated $61.9 million decrease in the fair value of equity securities.
- Accounting Changes: The company is assessing the impact of new FASB standards (SFAS 141, 142, 143, 144) regarding business combinations, goodwill, and asset retirement obligations, which will affect future reporting.
Investor Verification Checklist
- Non-Recurring Gains: Verify the sustainability of earnings by excluding the $362.4 million after-tax gain from the Litton/Northrop transaction when analyzing core operating performance.
- Insurance Loss Ratios: Monitor the trend in storm losses and adverse reserve development in the Multi Lines and Specialty Lines segments, which are currently driving operating losses.
- Legal Exposure: Track the status of the industrial life insurance litigation and potential settlement costs, which could materially impact future results despite the 2000 charge.
- Spin-Off Execution: Confirm the completion of the Curtiss-Wright spin-off and its impact on the company's asset base and future dividend policy.
- Investment Concentration: Assess the risk associated with the high concentration of equity investments in Northrop Grumman and Baker Hughes relative to total assets.